n3D
Develops magnetic 3D cell culture and bioprinting systems using nanoparticle magnetization to levitate or print cells into microtissues for drug discovery and biomedical research.
- CEO / Founder
- Glauco Souza (former CEO; company acquired 2018)
- Team Size
- 1-10
- Stage
- Acquired
- Total Funding
- $250K
- Latest Round
- Grant
- Key Investors
- Houston Technology Center, Texas Emerging Technology Fund, US National Science Foundation
Technology & Products
Key Products
Bio-Assembler (magnetic levitation device); NanoShuttle-PL (magnetization reagent); 96-well Bio-Assembler format; 3D bioprinting systems for drug screening; Cell culture kits and accessories
Technological Advantage
Technology protected by 11 patents (invented/co-invented by Glauco R. Souza) covering magnetic 3D cell culture; offers speed advantage (assembly in minutes) and ease of use over conventional 3D culture methods, with broad cell type compatibility.
Differentiation
Value Proposition
Enables rapid 3D cell culture assembly (minutes vs. days for traditional methods) with easy magnetic handling, reducing sample loss and improving throughput for high-content screening, while maintaining compatibility with any cell type and media.
How They Differentiate
Uses magnetic levitation instead of extrusion or inkjet bioprinting, enabling scaffold-free 3D tissue formation with faster assembly (minutes vs. hours/days) and easier handling via magnets, reducing technical barriers for researchers.
Market & Competition
Target Customers
Biomedical and pharmaceutical research labs, drug discovery companies, academic institutions
Industry Verticals
Pharmaceutical; Biotechnology; Academic Research; Drug Discovery; Toxicology Testing
Competitors
Organovo Holdings; CELLINK; 3D Systems Corporation
Growth & Milestones
Growth Metrics
Award recipient of Texas Emerging Technology Fund (TETF), National Science Foundation SBIR Phase I and Phase II awards, and Goradia Innovation Prize; worldwide distribution network including OEM partnership with Greiner Bio-One
Major Milestones
Founded in 2008; Released 96-well Bio-Assembler for 3D cell culture; Greiner Bio-One acquired 3D Cell Culture Technology assets from Nano3D Biosciences in May 2018; Partnership with Rainbow Biosciences for BiO Assay commercialization; Global distribution agreement with Reprocell
Notable Customers
Greiner Bio-One; SBH Sciences; Rainbow Biosciences (RBCC subsidiary)